WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo...
Transcript of WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo...
![Page 1: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/1.jpg)
WILL WE EVER CURE BREAST CANCER ?
![Page 2: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/2.jpg)
WHAT EXPLAINS THIS REMARKABLE ACHIEVEMENT ?
IMPROVEMENTS IN DETECTION
IMPROVEMENTS IN PREVENTION
SUCCESSFUL ADJUVANT THERAPY
![Page 3: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/3.jpg)
![Page 4: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/4.jpg)
![Page 5: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/5.jpg)
IS BREAST CANCER ACTUALLY EVER CURABLE ?
![Page 6: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/6.jpg)
![Page 7: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/7.jpg)
William Stewart Halsted
![Page 8: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/8.jpg)
Surgery does seem to matter
![Page 9: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/9.jpg)
Trials of radiotherapy after mastectomy
and axillary dissection
Local recurrence by use of systemic therapy
Note: one trial did not supply local recurrence information, affecting 20 women in this pN category.
![Page 10: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/10.jpg)
Axillary Lymph Node Metastases
Haagensen, Columbia Presbyterian 1935-1972; Mastectomy only-no adjuvant systemic therapy
Stage A 10 year Survival
1-3+ nodes 70.5%
4-7+ nodes 42.9%
>7+ nodes 18.8%
Stage B
1-3+ nodes 44.4%
4-7+ nodes 35.7%
>7+ nodes 15.6%
Haagensen, Diseases of the Breast 3rd Ed. 1986
![Page 11: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/11.jpg)
What do we make of lymph node metastases ?
Why does 1 or 2 or 3 or 4 lymph nodes involved with
breast cancer have such profound predictive value ?
Why are microscopic lymph node metastases so relatively
unimportant ?
![Page 12: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/12.jpg)
WHY DO SCATTERED BREAST CANCER CELLS IN A
LYMPH NODE HAVE A DIFFERENT PROGNOSIS FROM
A SMALL 2MM TUMOR MASS ?
AND WHY ARE PATIENTS WITH AXILLARY LYMPH NODES
COMMONLY CURABLE [ EVEN WITHOUT ADJUVANT THERAPY IN
SOME CASES ] WHILE PATIENTS WITH SUPRCLAVICULAR NODES
ALMOST NEVER ARE.
![Page 13: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/13.jpg)
![Page 14: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/14.jpg)
![Page 15: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/15.jpg)
![Page 16: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/16.jpg)
![Page 17: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/17.jpg)
Braun, S. et al. N Engl J Med 2005;353:793-802
Bone Marrow Metastases: Pooled Analysis
![Page 18: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/18.jpg)
Overall Survival, Median = 21.3 months
Progression-Free Survival, median = 11.5 months0.8
0.6
0.4
0.2
24 46 72 96 120 144 168 192 2160
0.0
1.0
240
Months From the Start of Treatment
Pro
po
rtio
n S
urv
ivin
g
Overall and progression free survival of 1581 patients with metastatic breast carcinoma treated on 18 successive, doxorubicin-containing standard dose chemotherapy protocols from 1973 to 1982 at the M.D. Anderson Cancer Center.
SURVIVAL FOLLOWING THE DIAGNOSIS OF METASTATIC BREAST CANCER
![Page 19: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/19.jpg)
Why can we ‘cure’ in the adjuvant setting
and not with ‘real’ metastatic disease ?
And why is bulky locally advanced breast cancer ‘better’
than a small skin metastasis ?
![Page 20: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/20.jpg)
![Page 21: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/21.jpg)
Metastatic Breast Cancer
Why [mostly] do multiple sites of metastasis appear more
or less at the same time ?
![Page 22: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/22.jpg)
WHY DON’T WE DO THE RIGHT THING ??
BREAST CANCER PREVENTION
ANTI-INFLAMMATORY TREATMENT
![Page 23: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/23.jpg)
The Lancet · Volume 379· No. 9826· Pages 1602-1612· April 28, 2012
![Page 24: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/24.jpg)
![Page 25: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/25.jpg)
The Lancet · Volume 379· No. 9826· Pages 1591-1601· April 28, 2012
![Page 26: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/26.jpg)
![Page 27: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/27.jpg)
![Page 28: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/28.jpg)
George Thomas Beatson, M.D.
![Page 29: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/29.jpg)
![Page 30: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/30.jpg)
The Lancet Oncology· Volume 13· Issue 5· Pages 476-486· May 2012
![Page 31: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/31.jpg)
![Page 32: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/32.jpg)
![Page 33: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/33.jpg)
![Page 34: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/34.jpg)
![Page 35: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/35.jpg)
![Page 36: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/36.jpg)
![Page 37: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/37.jpg)
How much does the “host” matter ?
Inflammation
Obesity
Depression
![Page 38: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/38.jpg)
THREE BIG ISSUES
MANY PATIENTS WHO APPARENTLY HAVE RESIDUAL BREAST CANCER EITHER DO NOT RELAPSE OR DO SO AT DELAYED TIMES WHICH ARE EXCEEDINGLY HARD TO EXPLAIN BY ANY KNOWN GROWTH KINETICS.
HOST FACTORS WHICH CAN CHANGE OVER TIME AND WHICH ARE UNLIKELY TO BE ASSOCIATED WITH PRIMARY CHANGES IN TUMOR CELLS THEMSELVES CLEARLY AFFECT RELAPSE AND SURVIVAL
EXACTLY THE SAME THERAPY WHICH CAN PREVENT BREAST CANCER AND APPARENTLY CURE MANY PATIENTS NEVER PROVIDES A CURE IN THE METASTATIC SETTING.
![Page 39: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/39.jpg)
The ‘classic’ model of cancer
A normal cell is ‘changed’ or transformed into a cancer cell.
In inherited forms of cancer one of these changes or mutations is already present.
Multiple changes in cells eventually result in full blown malignancy
Blocking any of these steps will result in successful treatment.
![Page 40: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/40.jpg)
TUMOR CELL SPECIFIC ANALYSES
THE ‘TRADITIONAL’ WAY TO GO
![Page 41: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/41.jpg)
![Page 42: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/42.jpg)
![Page 43: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/43.jpg)
Tumour Phylogenetic Evolution(Renal Cell Cancer)
NormalKDM5C (missense)
Gerlinger, M., et al.; N Engl J Med; 2012
![Page 44: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/44.jpg)
1.00E+00
1.00E+01
1.00E+02
1.00E+03
Log
Mu
tati
on
Rat
e p
er
10
Me
gab
ase
s
Background Mutation Rates Across Different Cancer Types
1 per Mbp
10 per Mbp
100 per Mbp
Pediatric cancers
De novo and secondary AMLs
GBMs OVCs BRCs LUCs
![Page 45: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/45.jpg)
CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE CYTOKINE PRODUCTION OF BREAST CANCERS TO
INDUCE METASTASIS ?
![Page 46: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/46.jpg)
IN OTHER WORDS, CAN WE USE THIS
INFORMATION TO FIGURE OUT HOW A
WOMAN’S BODY ALTERS THE RISK OF
OCCURRENCE AND RECURRENCE OF
BREAST CANCER ?
AND, CAN WE EXPLOIT THIS
THERAPEUTICALLY?
![Page 47: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/47.jpg)
All his life he suffered spells of depression,
sinking into the brooding depths of
melancholia, an emotional state which, though
little understood, resembles the passing
sadness of the normal man as a malignancy
resembles a canker sore.
William Manchester,
The Last Lion, Winston Spencer Churchill, Vol. I: Visions of Glory
(New York: Little, Brown & Company, 1989, p. 23)
47
![Page 48: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/48.jpg)
48
Psychological Medicine (2010), 40, 1797–1810
![Page 49: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/49.jpg)
![Page 50: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/50.jpg)
Psychologic intervention
improves survival for breast
cancer patients:
A randomized clinical trial
Andersen et al., Cancer
113: 3450-3458, 2008
(N = 227; Median Follow-up 11 years)
![Page 51: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/51.jpg)
Randomized Trials Showing Survival BenefitStudy Cancer N Psychological Outcome
Spiegel et al 1989 Metastatic Breast
Cancer
86 Less distress, pain
Richardson et al,
1990
Lymphoma,
leukemia
94 Better treatment adherence
Fawzy et al, 1993 Melanoma 66 Less distress, Better coping
Kuchler et al, 1999 GI cancers 271 Better stress management
McCorkle et al
2000
Solid Tumors 375 Less distress
Spiegel et al, 2007 Metastatic Breast
Cancer
125 Less distress, pain
Survival Interaction with ER
Status
Andersen et al,
2010
Primary Breast
Cancer
62 Improved Coping
Temel et al, 2010 Non Small Cell
Lung Cancer
107 Improved Q of L
Reduced Depression
![Page 52: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/52.jpg)
Post-surgical depressive symptoms and long-
term survival in non-metastatic breast cancer
patients at 11-year follow-up
Michael H. Antoni, PhDa,b,c,1, Jamie M. Jacobs, PhDd,⁎,1, Laura C. Bouchard,
MS a, Suzanne C. Lechner, PhDb,c,
Devika R. Jutagir, MSa, Lisa M. Gudenkauf, PhDa, Bonnie B. Blomberg, PhDc,e,
Stefan Glück, MD, PhDf, Charles S. Carver, PhDa,c
a Department of Psychology, University of Miami, Coral Gables, FL, United States
b Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States
c Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL, United States
d Massachusetts General Hospital Cancer Center, Center for Psychiatric Oncology and Behavioral Sciences and Cancer Outcomes
Research Program, Boston, MA, United States
e Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, United States
f Celgene Corporation, United States
Gen Hosp Psychiatry. 2017 Jan - Feb;44:16-21. doi:
10.1016/j.genhosppsych.2016.10.002. Epub 2016 Oct 22.
![Page 53: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/53.jpg)
High depressive symptoms significantly associate
with poorer survival in breast cancer patients
Low symptoms: HDRS ≤ 7
High symptoms: HDRS > 7
Log-rank p-value = 0.036
![Page 54: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/54.jpg)
![Page 55: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/55.jpg)
We wanted to develop a model which
would look at both the tumor AND the
‘’patient’’ simultaneously.
![Page 56: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/56.jpg)
56
Introduction
NSG model
• metastases frequently and consistently observed in orthotopic xenograft model using MDA231 cells in NSG mice
• 1x106 MDA231 cells injected into mammary fat pad of female NSG mice
• ~ 8 weeks post injection animals were sacrificed when tumors reached ~10% body weight according to IACUC guidelines
• animals were examined for presence of macroscopic metastases
1x106
MDA231 cells
![Page 57: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/57.jpg)
Macroscopic metastasis frequency in NSG model
Metastatic site Frequency (%)
Liver 89
Left axillary lymph node 74
Lung 47
Diaphragm 32
Right axillary lymph node 11
Kidney 11
Colon 5
Salivary gland 5
Fascia lymph node 5
Contralateral mammary fat pad 5
57
Introduction
NSG model
![Page 58: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/58.jpg)
Results
Stroma gene expression analysis: Analysis 3
• MOUSE ANALYSIS 3
• Identified genes differentially expressed between distant ‘normal’ stroma from tumor bearing mice and normal control stroma from non-tumor bearing mice
• Samples analyzed:
(2) distant ‘normal’ tissue not involved by tumor (mouse stroma)
(3) normal tissue from non-tumor bearing mice (mouse stroma)
RNA samples used for distant ‘normal’ stroma vs normal control stroma analyses
2
3
• primary mammary fat pad
• contralateral mammary fat pad
• liver
• diaphragm
![Page 59: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/59.jpg)
![Page 60: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/60.jpg)
![Page 61: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/61.jpg)
1
23
118
124
219
250
308
341
363
404
IgV
IgC
IgC
TM
ICD
Extracellular
Plasma membrane
Intracellular
Receptor for Advanced Glycation End-products (RAGE)
![Page 62: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/62.jpg)
Damage Associated Molecular Patterns (DAMPs)
RAGE is a multi-ligand receptor
Collagen I/IV
LPS
LPA
![Page 63: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/63.jpg)
![Page 64: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/64.jpg)
RAGE expression in breast tumor predict outcomes
RAGE IHC (n=205)
![Page 65: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/65.jpg)
Murine gene expression analysis of breast cancer-bearing stroma
shows upregulation of RAGE ligands
Drews-Elgers et al, BCRT, 2014
![Page 66: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/66.jpg)
RAGE gene knockout impairs breast cancer
progression
![Page 67: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/67.jpg)
RAGE inhibitor FPS-ZM1 impairs
breast cancer progression
500,000 4175 cells injected into NSG mice (n=10 per group).
FPS-ZM1 (1mg/kg, twice per week I.P.)
![Page 68: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/68.jpg)
RAGE inhibitor FPS-ZM1 impairs tumor metastasis
(RAGE knockdown model)
![Page 69: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/69.jpg)
TO SUM UP
LOCAL THERAPY MATTERS BUT IT’S NOT LIKELY TO
FURTHER IMPROVE SURVIVAL VERY MUCH
WE COULD LIKELY PREVENT A LOT OF BREAST
CANCER IF WE ACTED ON WHAT WE ALREADY
KNOW
GOING AFTER MUTATIONS ONE AT A TIME IS
GOING TO BE A VERY SLOW AND POSSIBLY
UNREWARDING STRATEGY
THE HOST REALLY MATTERS AND I PREDICT WILL
YIELD MORE SUCCESSES NEAR TERM THAN
“PERSONALIZED” MEDICINE
![Page 70: WILL WE EVER CURE BREAST CANCERbreastcancerconference.org/wp-content/uploads/2018/... · De novo and secondary AMLs GBMs OVCs BRCs LUCs. CAN SYSTEMIC INFLAMMATORY DISEASES MIMIC THE](https://reader035.fdocuments.net/reader035/viewer/2022062910/5bb5d22d09d3f250788d9308/html5/thumbnails/70.jpg)
I CANNOT SUFFICIENTLY THANK THE
AMAZINGLY PEOPLE IN WHOSE TRAINING I HAVE
BEEN PRIVILEGED TO PARTICIPATE
LARRY NORTON NEAL ROSEN
KENT OSBORNE RAIMUND JAKESZ
NANCY DAVIDSON SOON PAIK
BOB DICKSON MATTHEW ELLIS
DOUG YEE ROBERT CLARKE
ED GELMANN NILS BRUNNER
KEVIN CULLEN MICHAEL JOHNSON
SANDRA SWAIN CLAUDINE ISAACS
DORRAYA EL ASHRY GEORGE WILDING
JAMES RAE ERIK GOKA
ELIZABETH IORNS ANTON WELLSTEIN